Definitive Healthcare Corp. (DH) shares plummeted 13.62% in the after-hours trading session on Thursday, following the company's financial results for the fourth quarter and full fiscal year 2024. The healthcare commercial intelligence provider reported a significant net loss due to substantial goodwill impairment charges, along with a weak outlook for the first quarter of 2025.
In the fourth quarter of 2024, Definitive Healthcare recorded a net loss of $84.7 million, or 136% of revenue, largely driven by $97.1 million in goodwill impairment charges. The company's adjusted EBITDA declined to $17.5 million, or 28% of revenue, compared to $19.8 million, or 30% of revenue, in the same period last year.
For the full year 2024, Definitive Healthcare reported a net loss of $591.4 million, or 235% of revenue, including goodwill impairment charges of $688.9 million. While the company's revenue grew marginally to $252.2 million, its adjusted EBITDA margin improved slightly to 31% from 30% in 2023.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.